ERCC8 and osteosarcoma: Notably, ERCC8 and XPA have been previously implicated in DDP resistance,[16, 17] and we also demonstrated that they regulated the sensitivity of osteosarcoma cells to DDP treatment (Figure S1A,B, Supporting Information).